1993
DOI: 10.1016/0016-5085(93)90735-u
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal expression of anion exchanger genes in primary biliary cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
89
0
3

Year Published

1994
1994
2020
2020

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 131 publications
(99 citation statements)
references
References 28 publications
7
89
0
3
Order By: Relevance
“…[17][18][19][20]39,43 Our data may provide a missing pathophysiologic link in the pathogenesis of PBC, which, in our view, is based on the interplay between genetic, exogenous, and endogenous predisposing factors. [17][18][19][20]39,43 Future therapeutic approaches might, therefore, aim to further strengthen the weakened biliary HCO À 3 umbrella in PBC. 7 Advances have been made in understanding the mechanisms and sites of action of ursodeoxycholic acid (UDCA) in the therapy of chronic cholangiopathies.…”
Section: Discussionmentioning
confidence: 78%
See 2 more Smart Citations
“…[17][18][19][20]39,43 Our data may provide a missing pathophysiologic link in the pathogenesis of PBC, which, in our view, is based on the interplay between genetic, exogenous, and endogenous predisposing factors. [17][18][19][20]39,43 Future therapeutic approaches might, therefore, aim to further strengthen the weakened biliary HCO À 3 umbrella in PBC. 7 Advances have been made in understanding the mechanisms and sites of action of ursodeoxycholic acid (UDCA) in the therapy of chronic cholangiopathies.…”
Section: Discussionmentioning
confidence: 78%
“…23 Ischemia-type biliary lesions and nonanastomotic bile duct strictures after liver transplantation with denervation in man 42 may be a consequence of disrupted vagal acetylcholine signaling, a physiologic driving force of biliary HCO À Our data may have particular impact on the understanding of the pathogenesis and treatment of PBC. [17][18][19][20]39,43 Increasing evidence supports the view that cholangiocyte apoptosis is a driving force in the pathogenesis of PBC: It has long been demonstrated that cholangiocyte apoptosis is associated with ductular inflammation in PBC, but not PSC. 44 Furthermore, cholangiocytes of small bile ducts expose immunologically reactive PDC-E2 or PDC-E2-like protein during apoptosis, 16 which might explain, in part, the organ specificity of the immune reaction in PBC.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…In human liver, the expression of the AE2 message has been shown by reverse transcription-polymerase chain reaction on total RNA (Prieto et al 1993). Immunocytochemical studies on human liver, using a monoclonal antibody against a synthetic AE2 peptide, have shown that immunoreactivity is restricted to the canicular membrane of hepatocytes and to the luminal surfaces of intrahepatic bile ducts (Martínez-Ansó et al 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the first 17 amino acid triplets of AE2a are replaced by 3 triplets for residues MTQ in AE2b 1 and by 8 triplets for residues MDFLLRPQ in AE2b 2 . In addition to the mRNA level [9][10][11], liver expression of the human AE2 gene has been substantiated at the protein level by using a monoclonal antibody against an AE2 peptide common to all three AE2 isoforms [12]. This study showed AE2 immunoreactivity restricted to the lumenal surface of the hepatobiliary tree [12].…”
mentioning
confidence: 96%